-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Crohn's disease in the body can medsci.
Crohn's disease in the body can medsci.
Since 2005, a total of 12,904 CD patients have been included in this study (including 2,186 children ), and a total of 86,119 person-years of follow-up records have been collected.
Child diagnosis
Figure: The impact of perianal Crohn's disease on the prognosis of patients
Although facing the treatment of Crohn's disease drugs became more varied, immune utilization regulators and biological agents have become increasingly demanding, but the effect of treatment of PCD is still poor, and the PCD and diseases associated with poor prognosis, especially in severe This relationship is more obvious in PCD.
Although facing the treatment of Crohn's disease drugs became more varied, immune utilization regulators and biological agents have become increasingly demanding, but the effect of treatment of PCD is still poor, and the PCD and diseases associated with poor prognosis, especially in severe This relationship is more obvious in PCD.
Original source:
Ohad Atia.
Perianal Crohn's disease is associated with poor disease outcome: a nation-wide study from the epiIIRN cohort.
Leave a message here